Lupus Nephritis Therapy Response Predicts Survival Odds
Complete response to induction therapy is associated with significant 82% decreased odds of death at 12 months.
All articles by Jody A. Charnow
Urine Immunoassay Identifies Novel Lupus Nephritis Biomarkers
Using electrochemiluminescence, researchers found 5 urinary proteins that have “reasonable specificity” for lupus nephritis.
Gout Increases Risk for Chronic Kidney Disease
Gout may be a risk factor for the development of CKD stage ≥3.
Panel Issues Consensus Statement on Management of Gouty Arthritis of the Foot and Ankle
An expert panel evaluated 23 separate statements related to the etiology, diagnosis, and treatment of gout.
High Gout Burden Found Among Solid Organ Transplant Recipients
Study reveals an 11% prevalence of active gout among solid organ transplant recipients overall and a 13% prevalence among kidney transplant recipients.
Failure to Meet Optimal Urate Levels Increases Mortality Risk in Gout
Patients with gout who did not reach a serum uric acid level below 6 mg/dL had a 2.4-fold increased risk for death.
Gout Outcomes Improved With Nurse-Led Care
In a British study, nurse-led care emphasizing patient education and engagement significantly improved the proportion of gout sufferers who achieved target serum urate levels.
Gout Attack Risk Lowered With Interleukin-1ß Blockade
Inhibition of IL-1ß with canakinumab significantly decreased gout attack risk at all baseline serum uric acid (SUA) levels and without changing SUA levels.
Tacrolimus Possibly Beneficial Long Term in Lupus Nephritis
Over a 5-year period, the drug was well tolerated and associated with significant declines in urinary protein-creatinine ratio and mean prednisolone dose.
Patients With Gout Have Lower Prevalence of Colorectal Cancer
The 10-year prevalence of colonoscopy-documented colorectal cancer was 0.8% among gout patients vs 3.7% among osteoarthritis patients.
-
Loading...
-
Loading...
Next post in Gout
